Diagnosis and management of malignant pleural effusions

Respirology

Volumn 13, Issue 1, 2008, Pages 5-20

  Heffner, John E ^a,b  

^a Portland Providence Cancer Center   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Malignant; Pleural abnormality; Pleural disease; Pleural effusion; Pleurodesis; Thoracoscopy

Indexed keywords

ALPHA2B INTERFERON; BACTERIAL ANTIGEN; BLEOMYCIN; CHLORMETHINE; CORTICOSTEROID; DOXYCYCLINE; KETOPROFEN; MEPACRINE; MITOXANTRONE; NONSTEROID ANTIINFLAMMATORY AGENT; PICIBANIL; POVIDONE IODINE; SCLEROSING AGENT; SILVER NITRATE; TALC; TETRACYCLINE;

BREAST CARCINOMA; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; EFFUSION; GASTROINTESTINAL CARCINOMA; HUMAN; LUNG BIOPSY; LUNG CARCINOMA; LYMPHOMA; OVARY CARCINOMA; PALLIATIVE THERAPY; PLEURA BIOPSY; PLEURA CAVITY; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; THORACOCENTESIS; THORACOSCOPY;

BIOPSY; DIAGNOSTIC IMAGING; HUMANS; PARACENTESIS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS;

EID: 38049107782     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01154.x     Document Type: Review

References (232)

1. Rice TW, Rodriguez RM, Barnette R, Light RW. Prevalence and characteristics of pleural effusions in superior vena cava syndrome. Respirology 2006 11 : 299 305.
2. Sahn SA. State of the art. The pleura. Am. Rev. Respir. Dis. 1988 138 : 184 234.
3. Henschke CI, Yankelevitz DF, Davis SD. Pleural diseases: multimodality imaging and clinical management. Curr. Probl. Diagn. Radiol. 1991 20 : 155 81.
4. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974 33 : 916 22.
5. Storey DD, Dines DE, Coles DT. Pleural effusion. A diagnostic dilemma. JAMA 1976 236 : 2183 6.
6. Martinez-Moragon E, Aparicio J, Sanchis J, Menendez R, Cruz Rogado M et al. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 1998 65 : 108 13.
7. Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant pleural effusion. Cancer Metastasis Rev. 1987 6 : 23 40.
8. Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology 2007 18 : 28 32.
9. Ismail-Khan R, Robinson LA, Williams CC Garrett CR, Bepler G et al. Malignant pleural mesothelioma: a comprehensive review. Cancer Control 2006 13 : 255 63.
10. Das DK. Serous effusions in malignant lymphomas: a review. Diagn. Cytopathol. 2006 34 : 335 47.
11. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J. Clin. Oncol. 2005 23 : 4372 80.
12. Asakura H, Togami T, Mitani M, Takashima H, Yokoe K et al. Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma. Ann. Nucl. Med. 2005 19 : 725 8.
13. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000 117 : 79 86.
14. Jimenez D, Diaz G, Gil D, Cicero A, Perez-Rodriguez E et al. Aetiology and prognostic significance of massive pleural effusions. Respir. Med. 2005 99 : 1183 7.
15. Chen W, Shih CS, Wang YT, Tseng GC, Hsu WH. Angiosarcoma with pulmonary metastasis presenting with spontaneous bilateral pneumothorax in an elderly man. J. Formos. Med. Assoc. 2006 105 : 238 41.
16. Blackmore CC, Black WC, Dallas RV, Crow HC. Pleural fluid volume estimation: a CXR prediction rule. Acad. Radiol. 1996 3 : 103 9.
17. Tattersall M. Pleural effusions. Curr. Opin. Oncol. 1992 4 : 642 6.
18. Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin. Chest Med. 2006 27 : 193 213.
19. Colins JD, Burwell D, Furmanski S, Lorber P, Steckel RJ. Minimal detectable pleural effusions. A roentgen pathology model. Radiology 1972 105 : 51 3.
20. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J. Clin. Ultrasound 2003 31 : 69 74.
21. Gryminski J, Krakowka P, Lypacewicz G. The diagnosis of pleural effusion by ultrasonic and radiologic techniques. Chest 1976 70 : 33 7.
22. Chian CF, Su WL, Soh LH, Yan HC, Perng WC et al. Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies. Chest 2004 126 : 129 34.
23. Mayo PH, Doelken P. Pleural ultrasonography. Clin. Chest Med. 2006 27 : 215 27.
24. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am. J. Roentgenol. 1990 154 : 487 92.
25. Yilmaz U, Polat G, Sahin N, Soy O, Gulay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi. Arch. Chest Dis. 2005 63 : 17 22.
26. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin. Radiol. 2001 56 : 193 6.
27. Scott EM, Marshall TJ, Flower CD, Stewart S. Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy. Radiology 1995 194 : 867 70.
28. Hwang JH, Song KS, Park SI, Lim TH, Kwon KH et al. Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT. Korean J. Radiol. 2005 6 : 94 101.
29. Falaschi F, Battolla L, Zampa V, Cioni R, Cambi L et al. Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases. Radiol. Med. (Torino). 1996 92 : 713 18.
30. Hierholzer J, Luo L, Bittner RC, Stroszczynski C, Schroder RJ et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000 118 : 604 9.
31. Luo L, Hierholzer J, Bittner RC, Chen J, Huang L. Magnetic resonance imaging in distinguishing malignant from benign pleural disease. Chin. Med. J. 2001 114 : 645 9.
32. Lorigan JG, Libshitz HI. MR imaging of malignant pleural mesothelioma. J. Comput. Assist. Tomogr. 1989 13 : 617 20.
33. Davis SD, Henschke CL, Yankelevitz DF, Cahill PT, Yi Y. MR imaging of pleural effusions. J. Comput. Assist. Tomogr. 1990 14 : 192 8.
34. Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004 125 : 489 93.
35. Toaff JS, Metser U, Gottfried M, Gur O, Deeb ME et al. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography. Invest. Radiol. 2005 40 : 204 9.
36. Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004 125 : 2356 60.
37. Weiss N, Solomon SB. Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography. Clin. Nucl. Med. 2003 28 : 811 14.
38. Feinsilver SH, Barrows AA, Braman SS. Fiberoptic bronchoscopy and pleural effusion of unknown origin. Chest 1986 90 : 516 19.
39. Chakrabarti B, Ryland I, Sheard J, Warburton CJ, Earis JE. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest 2006 129 : 1549 55.
40. Thomsen TW, DeLaPena J, Setnik GS. Videos in clinical medicine. Thoracocentesis. N. Engl. J. Med. 2006 355 : e16.
41. Diacon AH, Schuurmans MM, Theron J, Schubert PT, Wright CA et al. Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. Respiration 2004 71 : 519 22.
42. Feller-Kopman D. Therapeutic thoracocentesis: the role of ultrasound and pleural manometry. Curr. Opin. Pulm. Med. 2007 13 : 312 18.
43. Feller-Kopman D. Ultrasound-guided thoracocentesis. Chest 2006 129 : 1709 14.
44. Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA et al. Sonographically guided thoracocentesis and rate of pneumothorax. J. Clin. Ultrasound 2005 33 : 442 6.
45. Villena V, Lopez-Encuentra A, Garcia-Lujan R, Echave-Sustaeta J, Martinez CJ. Clinical implications of appearance of pleural fluid at thoracocentesis. Chest 2004 125 : 156 9.
46. Ryu JS, Ryu ST, Kim YS, Cho JH, Lee HL. What is the clinical significance of transudative malignant pleural effusion? Korean J. Intern. Med. 2003 18 : 230 3.
47. Porcel JM, Alvarez M, Salud A, Vives M. Should a cytological study be ordered in transudative pleural effusions? Chest 1999 116 : 1836 7.
48. Heffner JE, Highland K, Brown LK. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am. J. Respir. Crit. Care Med. 2003 167 : 1591 9.
49. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997 111 : 970 80.
50. Matthai SM, Kini U. Diagnostic value of eosinophils in pleural effusion. A prospective study of 26 cases. Diagn. Cytopathol. 2003 28 : 96 9.
51. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, Hidalgo-Ramirez M, Perpina-Tordera M, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur. Respir. J. 2000 15 : 166 9.
52. Rubins JB, Rubins HB. Aetiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest 1996 110 : 1271 4.
53. Light RW. Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr. Opin. Pulm. Med. 1999 5 : 245 9.
54. Branca P, Rodriguez RM, Rogers JT, Ayo DS, Moyers JP et al. Routine measurement of pleural fluid amylase is not indicated. Arch. Intern. Med. 2001 161 : 228 32.
55. Villena V, Perez V, Pozo F, Lopez-Encuentra A, Echave-Sustaeta J et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. Chest 2002 121 : 470 4.
56. Sahn SA, Good JTJ. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann. Intern. Med. 1988 108 : 345 9.
57. Gottehrer A. Taryle DA, Reed CE, Sahn SA. Pleural fluid analysis in malignant mesothelioma. Prognostic implications. Chest 1991 100 : 1003 6.
58. Good JT Jr, Taryle DA, Maulitz RM, Kaplan RL, Sahn SA. The diagnostic value of pleural fluid pH. Chest 1980 78 : 55 9.
59. Sanchez-Armengol A, Rodrigues-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma revisited. Report of 125 cases. Chest 1993 104 : 1317 19.
60. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P et al. Management of malignant pleural effusions. Eur. Respir. J. 2001 18 : 402 19.
61. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Analysis of primary data. Chest 2000 117 : 87 95.
62. Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003 123 : 1887 94.
63. Hirsch A, Ruffie P, Nebut M. Pleural effusion: laboratory tests in 300 cases. Thorax 1979 34 : 106 12.
64. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975 67 : 536 9.
65. Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod. Pathol. 1991 4 : 320 4.
66. Prakash UB, Reiman HM. Comparison of needle biopsy with cytological analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin. Proc. 1985 60 : 158 64.
67. Woenckhaus M, Grepmeier U, Werner B, Schulz C, Rockmann F et al. Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J. Mol. Diagn. 2005 7 : 517 24.
68. Benlloch S, Galbis-Caravajal JM, Martin C, Sanchez-Paya J, Rodriguez-Paniagua JM et al. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 2006 107 : 1859 65.
69. Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002 122 : 1913 17.
70. Ong KC, Indumathi V, Poh WT, Ong YY. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Singapore Med. J. 2000 41 : 19 23.
71. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytologicalal diagnosis of malignancy. Mod. Pathol. 1994 7 : 665 8.
72. Porcel JM, Vives M, Esquerda A, Salud A, Perez B et al. Use of a panel of tumour markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004 126 : 1757 63.
73. Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest 2005 128 : 2298 303.
74. Shitrit D, Zingerman B, Shitrit AB, Shlomi D, Kramer MR. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist 2005 10 : 501 7.
75. Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K et al. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn. J. Clin. Oncol. 1997 27 : 293 7.
76. Lee JH, Hong YS, Ryu JS, Chang JH. p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion. Lung Cancer 2004 44 : 33 42.
77. Brock MV, Hooker CM, Yung R, Guo M, Han Y et al. Can we improve the cytological examination of malignant pleural effusions using molecular analysis? Ann. Thorac. Surg. 2005 80 : 1241 7.
78. Holloway AJ, Diyagama DS, Opeskin K, Creaney J, Robinson BW et al. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin. Cancer Res. 2006 12 : 5129 35.
79. Hung MS, Lin CK, Leu SW, Wu MY, Tsai YH et al. Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions. Chang Gung Med. J. 2006 29 : 373 9.
80. Fiegl M. The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion. Curr. Opin. Pulm. Med. 2005 11 : 313 18.
81. Osterheld MC, Liette C, Anca M. Image cytometry: an aid for cytologicalal diagnosis of pleural effusions. Diagn. Cytopathol. 2005 32 : 173 6.
82. Mungall IP, Cowen PN, Cooke NT, Roach TC, Cooke NJ. Multiple pleural biopsy with the Abrams needle. Thorax 1980 35 : 600 2.
83. Boutin C, Schlesser M, Frenay C, Astoul P. Malignant pleural mesothelioma. Eur. Respir. J. 1998 12 : 972 81.
84. Edmondstone WM. Investigation of pleural effusion. comparison between fibreoptic thoracoscopy, needle biopsy and cytology. Respir. Med. 1990 84 : 23 6.
85. McLean AN, Bicknell SR, McAlpine LG, Peacock AJ. Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram's needle biopsy. Chest 1998 114 : 150 3.
86. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003 361 : 1326 30.
87. Walshe ADP, Douglas JG, McKean ME, Godden DJ. An audit of the clinical investigation of pleural effusion. Br. Med. Assoc. 1992 47 : 734 7.
88. Cowie RL, Escreet BC, Goldstein B, Langton ME, Leigh RA. Pleural biopsy. A report of 750 biopsies performed using Abrams's pleural biopsy punch. S. Afr. Med. J. 1983 64 : 92 5.
89. Jimenez D, Perez-Rodriguez E, Diaz G, Fogue L, Light RW. Determining the optimal number of specimens to obtain with needle biopsy of the pleura. Respir. Med. 2002 96 : 14 17.
90. Benamore RE, Scott K, Richards CJ, Entwisle JJ. Image-guided pleural biopsy. diagnostic yield and complications. Clin. Radiol. 2006 61 : 700 5.
91. Light RW. The undiagnosed pleural effusion. Clin. Chest Med. 2006 27 : 309 19.
92. Celik M, Halezeroglu S, Senol C, Keles M, Yalcin Z et al. Video-assisted thoracoscopic surgery: experience with 341 cases. Eur. J. Cardiothorac. Surg. 1998 14 : 113 16.
93. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann. Intern. Med. 1991 114 : 271 6.
94. Tassi GF, Davies RJ, Noppen M. Advanced techniques in medical thoracoscopy. Eur. Respir. J. 2006 28 : 1051 9.
95. Mathur PN, Astoul P, Boutin C. Medical thoracoscopy. Technical details. Clin. Chest Med. 1995 16 : 479 86.
96. Ernst A, Hersh CP, Herth F, Thurer R, LoCicero J 3rd et al. A novel instrument for the evaluation of the pleural space: an experience in 34 patients. Chest 2002 122 : 1530 4.
97. Munavvar M, Khan MA, Edwards J, Waqaruddin Z, Mills J. The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur. Respir. J. 2007 29 : 571 4.
98. Lee YC, Light RW. Management of malignant pleural effusions. Respirology 2004 9 : 148 56.
99. Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003 58 (Suppl. 2 ii8 17.
100. Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F et al. Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 2006 129 : 718 24.
101. Chrysanthidis MG, Janssen JP. Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results. Eur. Respir. J. 2005 26 : 989 92.
102. Bueno R, Reblando J, Glickman J, Jaklitsch MT, Lukanich JM et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann. Thorac. Surg. 2004 78 : 1774 6.
103. Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I et al. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005 127 : 1017 22.
104. Sahn SA. Management of malignant pleural effusions. Monaldi. Arch. Chest Dis. 2001 56 : 394 9.
105. Huggins JT, Doelken P. Pleural manometry. Clin. Chest Med. 2006 27 : 229 40.
106. Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracocentesis. Chest 2006 129 : 1556 60.
107. Sorensen PG, Svendsen TL, Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur. J. Respir. Dis. 1984 65 : 131 5.
108. Groth G, Gatzemeier U, Haussingen K, Heckmayr M, Magnussen H et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann. Oncology 1991 2 : 213 15.
109. Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 2003 58 (Suppl. 2 ii29 38.
110. Marom EM, Patz EF Erasmus JJ, McAdams HP, Goodman PC et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999 210 : 277 81.
111. Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann. Thoracic. Surg. 1976 22 : 8 15.
112. Schulze M, Boehle AS, Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann. Thorac. Surg. 2001 71 : 1809 12.
113. Jones GR Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis. Thorax 1969 24 : 69 73.
114. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest 1994 106 : 342 6.
115. Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005 127 : 909 15.
116. Bernard A, de Dompsure RB, Hagry O, Favre JP. Early and late mortality after pleurodesis for malignant pleural effusion. Ann. Thorac Surg. 2002 74 : 213 17.
117. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions. an assessment of the prognostic values of physiologic, morphological, and quality of life measures of extent of disease. Chest 2000 117 : 73 8.
118. Steger V, Mika U, Toomes H, Walker T, Engel C et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann. Thorac. Surg. 2007 83 : 1940 5.
119. Boland GW, Gazelle GS, Girard MJ, Mueller PR. Asymptomatic hydropneumothorax after therapeutic thoracocentesis for malignant pleural effusions. Am. J. Roentgenol. 1998 170 : 943 6.
120. Chang YC, Patz EF Goodman PC. Pneumothorax after small-bore catheter placement for malignant pleural effusions. Am. J. Roentgenol. 1996 166 : 1049 51.
121. Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracocentesis. Chest 2006 130 : 1173 84.
122. Huggins JT, Sahn SA, Heidecker J, Ravenel JG, Doelken P. Characteristics of trapped lung. pleural fluid analysis, manometry, and air-contrast chest CT. Chest 2007 131 : 206 13.
123. Crnjac A, Sok M, Kamenik M. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur. J. Cardiothorac. Surg. 2004 26 : 432 6.
124. Lee YC, Baumann MH, Maskell NA, Waterer GW, Eaton TE et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003 124 : 2229 38.
125. Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir. Med. 1998 92 : 593 6.
126. Patz EF Jr. Malignant pleural effusions: recent advances and ambulatory sclerotherapy. Chest 1998 113 : 74S 7S.
127. Patz EF McAdams HP, Erasmus JJ, Goodman PC, Culhane DK et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998 113 : 1305 11.
128. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001 120 : 19 25.
129. Hsu WH, Chiang CD, Chen CY, Kwan PC, Hsu JY. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn. J. Clin. Oncol. 1998 28 : 187 91.
130. Sahin U, Unlu M, Akkaya A, Ornek Z. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions. Respiration 2001 68 : 501 5.
131. Sartori S, Tombesi P, Tassinari D, Ceccotti P, Nielsen I et al. Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions. J. Ultrasound Med. 2004 23 : 1171 6.
132. Saffran L. Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000 118 : 417 21.
133. Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006 54 : 51 5.
134. Yildirim E, Dural K, Yazkan R, Zengin N, Yildirim D et al. Rapid pleurodesis in symptomatic malignant pleural effusion. Eur. J. Cardiothorac. Surg. 2005 27 : 19 22.
135. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest 2003 123 : 1895 8.
136. Marom EM, Erasmus JJ, Herndon JE, 2nd, Zhang C, McAdams HP. Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. Am. J. Roentgenol. 2002 179 : 105 8.
137. Pollak JS. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr. Opin. Pulm. Med. 2002 8 : 302 7.
138. Verfaillie G, Herreweghe RV, Lamote J, Noppen M, Sacre R. Use of a Port-a-Cath system in the home setting for the treatment of symptomatic recurrent malignant pleural effusion. Eur. J. Cancer Care (Engl.) 2005 14 : 182 4.
139. Alisky JM. Implantable central venous access ports for minimally invasive repetitive drainage of pleural effusions. Med. Hypotheses 2007 68 : 910 1.
140. Jacobi CA, Wenger FA, Schmitz-Rixen T, Muller JM. Talc pleurodesis in recurrent pleural effusions. Langenbecks Arch. Surg. 1998 383 : 156 9.
141. Mager HJ, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002 36 : 77 81.
142. Dryzer SR, Allen ML, Strange C, Sahn SA. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993 104 : 1763 6.
143. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg. 2006 29 : 829 38.
144. Teixeira LR, Vargas FS, Acencio MM, Paz PF, Antonangelo L et al. Influence of antiinflammatory drugs (methylprednisolone and diclofenac sodium) on experimental pleurodesis induced by silver nitrate or talc. Chest 2005 128 : 4041 5.
145. Teixeira LR, Wu W, Chang DS, Light RW. The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits. Chest 2002 121 : 216 19.
146. Xie C, Teixeira LR, McGovern JP, Light RW. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am. J. Respir. Crit. Care Med. 1998 157 : 1441 4.
147. Haddad FJ, Younes RN, Gross JL, Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J. Surg. 2004 28 : 749 53 discussion 53 4.
148. Liao H, Guo Y, Jun Na M, Lane KB, Light RW. The short-term administration of ketoprofen does not decrease the effect of pleurodesis induced by talc or doxycycline in rabbits. Respir. Med. 2007 101 : 963 8.
149. Hsu LH, Soong TC, Feng AC, Liu MC. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J. Thorac. Oncol. 2006 1 : 460 7.
150. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst. Rev. 2004 1 : CD002916.
151. Debeljak A, Kecelj P, Triller N, Letonja S, Kern I et al. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions. J. BUON. 2006 11 : 463 7.
152. Ukale V, Agrenius V, Hillerdal G, Mohlkert D, Widstrom O. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug. Lung Cancer 2004 43 : 323 8.
153. Paschoalini Mda S, Vargas FS, Marchi E, Pereira JR, Jatene FB et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005 128 : 684 9.
154. Kuzdzal J, Sladek K, Wasowski D, Soja J, Szlubowski A et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med. Sci. Monit. 2003 9 : PI54 9.
155. Ong KC, Indumathi V, Raghuram J, Ong YY. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000 5 : 99 103.
156. Marchi E, Vargas FS, Acencio MM, Antonangelo L, Genofre EH et al. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur. Respir. J. 2006 28 : 929 32.
157. Antony VB, Nasreen N, Mohammed KA, Sriram PS, Frank W et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 2004 126 : 1522 8.
158. Godbey SW, Holm KA, Yu L, Hott JW, Panadero FR et al. Role of mesothelial cell in pleural fibrosis following successful talc poudrage: identification of basic fibroblast growth factor (FGF-2) in pleural fluids. Am. J. Respir. Crit. Care Med. 1995 151 : A353.
159. Najmunnisa N, Mohammed KA, Brown S, Su Y, Sriram PS et al. Talc mediates angiostasis in malignant pleural effusions via endostatin induction. Eur. Respir. J. 2007 29 : 761 9.
160. Nasreen N, Mohammed KA, Dowling PA, Ward MJ, Galffy G et al. Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am. J. Respir. Crit. Care Med. 2000 161 : 595 600.
161. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001 6 : 181 5.
162. Medford AR, Maskell NA. A national survey of oncologist and chest physicians' attitudes towards empirical anti-oestrogen therapy, early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease. Palliat. Med. 2005 19 : 430 1.
163. de Campos JR, Vargas FS, de Campos Werebe E, Cardoso P, Teixeira LR et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001 119 : 801 6.
164. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1989 86 : 795 7.
165. Chambers JS. Palliative treatment of neoplastic pleural effusion with intercostal intubation and talc instillation. West. J. Surg. Obstet. Gynecol. 1958 66 : 26 8.
166. Rinaldo JE, Owens GR, Roger RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J. Thorac. Cardiovasc. Surg. 1983 85 : 523 6.
167. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am. J. Surg. 1999 177 : 437 40.
168. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am. J. Respir. Crit. Care Med. 2004 170 : 377 82.
169. Ferrer J, Villarino MA, Tura JM, Traveria A, Light RW. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001 119 : 1901 5.
170. Kuzniar TJ, Blum MG, Kasibowska-Kuzniar K, Mutlu GM. Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann. Thorac. Surg. 2006 82 : 1976 81.
171. Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996 110 : 1387 93.
172. Weissberg D, Ben-Zeev I. Talc pleurodesis. Experience with 360 patients. J. Thorac. Cardiovasc. Surg. 1993 106 : 689 95.
173. Noppen M. Who's (still) afraid of talc? Eur. Respir. J. 2007 29 : 619 21.
174. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007 369 : 1535 9.
175. Ferrer J, Montes JF, Villarino MA, Light RW, Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002 122 : 1018 27.
176. Froudarakis ME, Klimathianaki M, Pougounias M. Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006 129 : 356 61.
177. Scalzetti EM. Unilateral pulmonary edema after talc pleurodesis. J. Thorac. Imaging 2001 16 : 99 102.
178. Lee YC, Lane KB, Zoia O, Thompson PJ, Light RW et al. Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur. Respir. J. 2003 22 : 197 202.
179. Gary Lee YC, Teixeira LR, Devin CJ, Vaz MA, Vargas FS et al. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am. J. Respir. Crit. Care Med. 2001 163 : 640 4.
180. Lee P, Colt HG. Rigid and semirigid pleuroscopy: the future is bright. Respirology 2005 10 : 418 25.
181. Katlic MR. Video-assisted thoracic surgery utilizing local anesthesia and sedation. Eur. J. Cardiothorac. Surg. 2006 30 : 529 32.
182. Arapis K, Caliandro R, Stern JB, Girard P, Debrosse D et al. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg. Endosc. 2006 20 : 919 23.
183. Brega-Massone PP, Lequaglie C, Magnani B, Ferro F, Cataldo I. Chemical pleurodesis to improve patients' quality of life in the management of malignant pleural effusions. the 15 year experience of the National Cancer Institute of Milan. Surg. Laparosc. Endosc. Percutan. Tech. 2004 14 : 73 9.
184. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur. J. Cardiothorac. Surg. 2002 21 : 302 5 discussion 5 6.
185. Crnjac A. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions. Wien. Klin. Wochenschr. 2004 116 (Suppl. 2 28 32.
186. Gasparri R, Leo F, Veronesi G, Depas T, Colleoni M et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 2006 106 : 271 6.
187. Marrazzo A, Noto A, Casa L, Taormina P, Lo Gerfo D et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J. Pain Symptom Manage. 2005 30 : 75 9.
188. Trotter D, Aly A, Siu L, Knight S. Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital's experience. Heart Lung Circ. 2005 14 : 93 7.
189. van den Toorn LM, Schaap E, Surmont VF, Pouw EM, van der Rijt KC et al. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005 50 : 123 7.
190. Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999 86 : 1992 9.
191. Putnam JB Walsh GL, Swisher SG, Roth JA, Suell DM et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann. Thorac. Surg. 2000 69 : 369 75.
192. Pollak JS, Burdge CM, Rosenblatt M, Houston JP, Hwu WJ et al. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J. Vasc. Interv. Radiol. 2001 12 : 201 8.
193. Tremblay A, Michaud G. Single-centre experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006 129 : 362 8.
194. Pien GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001 119 : 1641 6.
195. Musani AI, Haas AR, Seijo L, Wilby M, Sterman DH. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004 71 : 559 66.
196. Ohm C, Park D, Vogen M, Bendick P, Welsh R et al. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions. Am. Surg. 2003 69 : 198 202 discussion.
197. Wachsman AM, Hoffer EK, Forauer AR, Silas AM, Gemery JM. Tension pneumothorax after placement of a tunneled pleural drainage catheter in a patient with recurrent malignant pleural effusions. Cardiovasc. Intervent. Radiol. 2007 30 : 531 3.
198. Janes SM, Rahman NM, Davies RJ, Lee YC. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007 131 : 1232 4.
199. Little A, Kadowaki M, Ferguson M, Staszek VM, Skinner DB. Pleuroperitoneal shunting: alternative therapy for pleural effusions. Ann. Surg. 1988 208 : 443 50.
200. Petrou M, Kaplan D, Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 1995 75 : 801 5.
201. Genc O, Petrou M, Ladas G, Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur. J. Cardiothorac. Surg. 2000 18 : 143 6.
202. Artemiou O, Marta GM, Klepetko W, Wolner E, Muller MR. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann. Thorac. Surg. 2003 76 : 231 3.
203. Gupta D, Ross K, Piacentino V, 3rd, Stepnowski D, McClurken JB et al. Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax. Ann. Thorac. Surg. 2004 78 : e9 12.
204. Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 2005 128 : 1431 5.
205. Kilic D, Akay H, Kavukcu S, Kutlay H, Cangir AK et al. Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg. Today 2005 35 : 634 8.
206. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur. J. Cardiothorac. Surg. 2006 30 : 827 32.
207. Porcel JM, Salud A, Nabal M, Vives M, Esquerda A et al. Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions. Support Care Cancer 2006 10 : 1 4.
208. Heffner JE, Standerfer RJ, Torstveit J, Unruh L. Clinical efficacy of doxycycline for pleurodesis. Chest 1994 105 : 1743 7.
209. Sartori S, Tassinari D, Ceccotti P, Tombesi P, Nielsen I et al. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. J. Clin. Oncol. 2004 22 : 1228 33.
210. Moffett MJ, Ruckdeschel JC. Bleomycin and tetracycline in malignant pleural effusions: a review. Semin. Oncol. 1992 19 : 59 62 discussion -3.
211. Stiksa G, Korsgaard R, Simonsson BG. Treatment of recurrent pleural effusion by pleurodesis with quinacrine. Comparison between instillation by repeated thoracocenteses and by tube drainage. Scand. J. Respir. Dis. 1979 60 : 197 205.
212. Bayly TC, Kisner DL, Sybert A, Macdonald JS, Tsou E et al. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer 1978 41 : 1188 92.
213. Koldsland S, Svennevig JL, Lehne G, Johnson E. Chemical pleurodesis in malignant pleural effusions:a randomised prospective study of mepacrine versus bleomycin. Thorax 1993 48 : 790 3.
214. Banerjee AK, Willetts I, Robertson JF, Blamey RW. Pleural effusion in breast cancer. a review of the Nottingham experience. Eur. J. Surg. Oncol. 1994 20 : 33 6.
215. Olivares-Torres CA, Laniado-Laborin R, Chavez-Garcia C, Leon-Gastelum C, Reyes-Escamilla A et al. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002 122 : 581 3.
216. Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 2006 11 : 105 8.
217. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir. Med. 2006 100 : 2043 7.
218. Kelly-Garcia J, Roman-Berumen JF, Ibarra-Perez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch. Med. Res. 1997 28 : 583 5.
219. Agarwal R. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis. Lung Cancer 2007 55 : 253 4.
220. Foresti V. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions. Respiration 1995 62 : 21 6.
221. Hillerdal G, Kiviloog J, Nou E, Steinholtz L. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study. Eur. J. Respir. Dis. 1986 69 : 204 6.
222. McLeod DT, Calverley PM, Millar JW, Horne NW. Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax 1985 40 : 515 18.
223. Senyigit A, Bayram H, Babayigit C, Topcu F, Balci AE et al. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases. Respiration 2000 67 : 623 9.
224. Chella A, Ribechini A, Dini P, Adamo C, Mussi A et al. Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis. Minerva. Chir. 1994 49 : 1077 82.
225. Barbetakis N, Antoniadis T, Tsilikas C. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer. World J. Surg. Oncol. 2004 2 : 16.
226. Barbetakis N, Vassiliadis M, Kaplanis K, Valeri R, Tsilikas C. Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer. BMC Palliat. Care 2004 3 : 4.
227. Kelly J, Holmes EC, Rosen G. Mitoxantrone for malignant pleural effusion due to metastatic sarcoma. Surg. Oncology 1993 2 : 299 301.
228. Wilkins HE 3rd, Connolly MM, Grays P, Marquez G, Nelson D. Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest 1997 111 : 1597 9.
229. Sartori S, Trevisani L, Nielsen I, Tassinari D, Abbasciano V. Intracavitary bleomycin vs interferon in the management of malignant pleural effusions. Chest 1998 113 : 1145 6.
230. Ren S, Terman DS, Bohach G, Silvers A, Hansen C et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 2004 126 : 1529 39.
231. Kasahara K, Shibata K, Shintani H, Iwasa K, Sone T et al. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer. Anticancer Res. 2006 26 : 1495 9.
232. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ et al. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992 69 : 674 9.